speb/financial-data huggingface dataset:
IBTA balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 457283000.00
IBTA income_statement (annual, 2024-12-31) — Total Expenses: 339329000.00
IBTA balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 221146000.00
IBTA balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 96688000.00
IBTA balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 16981000.00
IBTA income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 27925000.00
IBTA income_statement (annual, 2024-12-31) — Total Other Finance Cost: -9414000.00
IBTA income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: -4111000.00
IBTA income_statement (annual, 2024-12-31) — Total Unusual Items: -9686000.00
IBTA income_statement (quarterly, 2024-12-31) — Total Unusual Items: -56000.00
IBTA income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -9686000.00
IBTA income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -56000.00
IBTA balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 16981000.00
IBTA balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 518683.00
IBTA balance_sheet (annual, 2024-12-31) — Treasury Stock: 31321000.00
IBTA balance_sheet (annual, 2024-12-31) — Working Capital: 377576000.00
IBTA income_statement (quarterly, 2025-03-31) — +Operating Expense: 70285000.00
IBTA income_statement (quarterly, 2025-03-31) — +Total Revenue: 84574000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 11303000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 206159000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -10035000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 645896000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -4086000.00
IBTA cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 582000.00
IBTA income_statement (quarterly, 2025-03-31) — Basic Average Shares: 30779430.00
IBTA income_statement (quarterly, 2025-03-31) — Basic EPS: 0.02
IBTA cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 349690000.00
IBTA cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -4968000.00
IBTA cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -3074000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 24510000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Capital Stock: 0.00
IBTA balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 297125000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 297125000.00
IBTA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -67049000.00
IBTA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -4968000.00
IBTA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 19860000.00
IBTA cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 273000.00
IBTA cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -3559000.00
IBTA cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -23890000.00
IBTA cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 22468000.00
IBTA cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 612000.00
IBTA cash_flow (quarterly, 2025-03-31) — Change In Payable: -7178000.00
IBTA cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -10737000.00
IBTA cash_flow (quarterly, 2025-03-31) — Change In Receivables: 14311000.00
IBTA cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 2764000.00
IBTA cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 14311000.00
IBTA cash_flow (quarterly, 2025-03-31) — Changes In Cash: -52157000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Common Stock: 0.00
IBTA balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 401276000.00
IBTA cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -69778000.00
IBTA income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 17092000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 6181000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Current Assets: 527986000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 5576000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 5576000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 196504000.00
IBTA cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 0.00
IBTA cash_flow (quarterly, 2025-03-31) — Deferred Tax: 0.00
IBTA cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 2165000.00
IBTA income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 972000.00
IBTA cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 2165000.00
IBTA income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 972000.00
IBTA income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 33218817.00
IBTA income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.02
IBTA income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 555000.00
IBTA income_statement (quarterly, 2025-03-31) — EBIT: -2803000.00
IBTA income_statement (quarterly, 2025-03-31) — EBITDA: -638000.00
IBTA cash_flow (quarterly, 2025-03-31) — End Cash Position: 297533000.00
IBTA cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -67049000.00
IBTA cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 14892000.00
IBTA cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 2161000.00
IBTA income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 21386000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 17573000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 210245000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Gross PPE: 25206000.00
IBTA income_statement (quarterly, 2025-03-31) — Gross Profit: 67482000.00
IBTA cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
IBTA cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 21000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Invested Capital: 401276000.00
IBTA cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -4968000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 4531000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 24510000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 24510000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 4531000.00
IBTA cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -69778000.00
IBTA income_statement (quarterly, 2025-03-31) — Net Income: 555000.00
IBTA income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 555000.00
IBTA income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 555000.00
IBTA income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 555000.00
IBTA income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 555000.00
IBTA cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 555000.00
IBTA income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 555000.00
IBTA income_statement (quarterly, 2025-03-31) — Net Interest Income: 3685000.00
IBTA income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 3685000.00
IBTA cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -631000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Net PPE: 15171000.00
IBTA cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -1894000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 383703000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 73211000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 73211000.00
IBTA income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -638000.00
IBTA income_statement (quarterly, 2025-03-31) — Normalized Income: 555000.00
IBTA cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 19860000.00
IBTA cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 2161000.00
IBTA income_statement (quarterly, 2025-03-31) — Operating Income: -2803000.00
IBTA income_statement (quarterly, 2025-03-31) — Operating Revenue: 84574000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 29519544.00
IBTA balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 24294000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 77961000.00
IBTA income_statement (quarterly, 2025-03-31) — Other Gand A: 21386000.00
IBTA income_statement (quarterly, 2025-03-31) — Other Income Expense: -399000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 17573000.00
IBTA cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 42000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 792000.00
IBTA income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -399000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Other Payable: 86531000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Other Properties: 25206000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Payables: 97834000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 104015000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 8952000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
IBTA income_statement (quarterly, 2025-03-31) — Pretax Income: 483000.00
IBTA cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 3360000.00
IBTA cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 418000.00
IBTA cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -1894000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Receivables: 206159000.00
IBTA income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 15899000.00
IBTA income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2165000.00
IBTA cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -69778000.00
IBTA income_statement (quarterly, 2025-03-31) — Research And Development: 18069000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 408000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -139891000.00
IBTA cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
IBTA income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 29858000.00
IBTA income_statement (quarterly, 2025-03-31) — Selling General And Administration: 51244000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Share Issued: 31878781.00
IBTA cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 11591000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 401276000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 383703000.00
IBTA income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
IBTA income_statement (quarterly, 2025-03-31) — Tax Provision: -72000.00
IBTA income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
IBTA balance_sheet (quarterly, 2025-03-31) — Total Assets: 639264000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 401276000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Total Debt: 24510000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 401276000.00
IBTA income_statement (quarterly, 2025-03-31) — Total Expenses: 87377000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 237988000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 111278000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 41484000.00
IBTA income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -2803000.00
IBTA income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: -3685000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 16974000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 2359237.00
IBTA balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 104729000.00
IBTA balance_sheet (quarterly, 2025-03-31) — Working Capital: 331482000.00
IBTA income_statement (quarterly, 2025-06-30) — +Operating Expense: 66866000.00
IBTA income_statement (quarterly, 2025-06-30) — +Total Revenue: 86029000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 10596000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 208976000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -10168000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 664427000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -4846000.00
IBTA cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 1113000.00
IBTA income_statement (quarterly, 2025-06-30) — Basic Average Shares: 28479977.00
IBTA income_statement (quarterly, 2025-06-30) — Basic EPS: 0.09
IBTA cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 297533000.00
IBTA cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -7000000.00
IBTA cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -3374000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 24923000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Capital Stock: 0.00
IBTA balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 250549000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 250549000.00
IBTA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -65781000.00
IBTA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -7000000.00
IBTA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 25855000.00
IBTA cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 853000.00
IBTA cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 2024000.00
IBTA cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 423000.00
IBTA cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -1084000.00
IBTA cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -428000.00
IBTA cash_flow (quarterly, 2025-06-30) — Change In Payable: 9035000.00
IBTA cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 11059000.00
IBTA cash_flow (quarterly, 2025-06-30) — Change In Receivables: -3848000.00
IBTA cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 6122000.00
IBTA cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -3848000.00
IBTA cash_flow (quarterly, 2025-06-30) — Changes In Cash: -46926000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Common Stock: 0.00
IBTA balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 354128000.00
IBTA cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -70398000.00
IBTA income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 17925000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 6447000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Current Assets: 482647000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 5148000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 5148000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 204033000.00
IBTA cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2445000.00
IBTA income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 1048000.00
IBTA cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2445000.00
IBTA income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 1048000.00
IBTA income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 30433519.00
IBTA income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.08
IBTA income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 2490000.00
IBTA income_statement (quarterly, 2025-06-30) — EBIT: 1238000.00
IBTA income_statement (quarterly, 2025-06-30) — EBITDA: 3683000.00
IBTA cash_flow (quarterly, 2025-06-30) — End Cash Position: 250607000.00
IBTA cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -65781000.00
IBTA cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 18855000.00
IBTA cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 2184000.00
IBTA income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 22264000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 19054000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 213822000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Gross PPE: 29569000.00
IBTA income_statement (quarterly, 2025-06-30) — Gross Profit: 68104000.00
IBTA cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 4090000.00
IBTA income_statement (quarterly, 2025-06-30) — Interest Income: 2636000.00
IBTA income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 2636000.00
IBTA cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 75000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Invested Capital: 354128000.00
IBTA cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -7000000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 4531000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 24923000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 24923000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 4531000.00
IBTA cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -70398000.00
IBTA income_statement (quarterly, 2025-06-30) — Net Income: 2490000.00
IBTA income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 2490000.00
IBTA income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 2490000.00
IBTA income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 2490000.00
IBTA income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 2490000.00
IBTA cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 2490000.00
IBTA income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 2490000.00
IBTA income_statement (quarterly, 2025-06-30) — Net Interest Income: 2636000.00
IBTA income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 2636000.00
IBTA cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -1416000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Net PPE: 19401000.00
IBTA cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -3626000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 335074000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 74407000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 74407000.00
IBTA income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 3683000.00
IBTA income_statement (quarterly, 2025-06-30) — Normalized Income: 2490000.00
IBTA cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 25855000.00
IBTA cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 2184000.00
IBTA income_statement (quarterly, 2025-06-30) — Operating Income: 1238000.00
IBTA income_statement (quarterly, 2025-06-30) — Operating Revenue: 86029000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 28377588.00
IBTA balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 23064000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 75745000.00
IBTA income_statement (quarterly, 2025-06-30) — Other Gand A: 22264000.00
IBTA income_statement (quarterly, 2025-06-30) — Other Income Expense: -6000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 19054000.00
IBTA cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 43000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 738000.00
IBTA income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -6000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Other Payable: 94713000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Other Properties: 29569000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Payables: 105309000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 111756000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 11384000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
IBTA income_statement (quarterly, 2025-06-30) — Pretax Income: 3868000.00
IBTA cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 6033000.00
IBTA cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -3626000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Receivables: 208976000.00
IBTA income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 16528000.00
IBTA income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2445000.00
IBTA cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -70398000.00
IBTA income_statement (quarterly, 2025-06-30) — Research And Development: 14745000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 58000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -137401000.00
IBTA income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 28809000.00
IBTA income_statement (quarterly, 2025-06-30) — Selling General And Administration: 51073000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Share Issued: 32185198.00
IBTA income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
IBTA cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 11458000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 354128000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 335074000.00
IBTA income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
IBTA income_statement (quarterly, 2025-06-30) — Tax Provision: 1378000.00
IBTA income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.36
IBTA balance_sheet (quarterly, 2025-06-30) — Total Assets: 600778000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 354128000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Total Debt: 24923000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 354128000.00
IBTA income_statement (quarterly, 2025-06-30) — Total Expenses: 84791000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 246650000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 118131000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 42617000.00
IBTA income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 1238000.00
IBTA income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
IBTA income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
IBTA balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 17694000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 3807610.00
IBTA balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 172898000.00
IBTA balance_sheet (quarterly, 2025-06-30) — Working Capital: 278614000.00
IBTA income_statement (quarterly, 2025-09-30) — +Operating Expense: 63752000.00
IBTA income_statement (quarterly, 2025-09-30) — +Total Revenue: 83260000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 15311000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 212822000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -10482000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 677505000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -5280000.00
IBTA cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 477000.00
IBTA income_statement (quarterly, 2025-09-30) — Basic Average Shares: 27995708.00
IBTA income_statement (quarterly, 2025-09-30) — Basic EPS: 0.05
IBTA cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 250607000.00
IBTA cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -11160000.00
IBTA cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -3912000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 25342000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Capital Stock: 0.00
IBTA balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 223296000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 223296000.00
IBTA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -37847000.00
IBTA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -11160000.00
IBTA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 21754000.00
IBTA cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 342000.00
IBTA cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -1499000.00
IBTA cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 21744000.00
IBTA cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -13963000.00
IBTA cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -458000.00
IBTA cash_flow (quarterly, 2025-09-30) — Change In Payable: 4330000.00
IBTA cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 2831000.00
IBTA cash_flow (quarterly, 2025-09-30) — Change In Receivables: -4318000.00
IBTA cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 5836000.00
IBTA cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -4318000.00
IBTA cash_flow (quarterly, 2025-09-30) — Changes In Cash: -27253000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Common Stock: 0.00
IBTA balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 329609000.00
IBTA cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
IBTA cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -38004000.00
IBTA income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 17142000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 5827000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Current Assets: 455460000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 4690000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 4690000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 206526000.00
IBTA cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1243000.00
IBTA income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 636000.00
IBTA cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1243000.00
IBTA income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 636000.00
IBTA income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 29376837.00
IBTA income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.05
IBTA income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 1533000.00
IBTA income_statement (quarterly, 2025-09-30) — EBIT: 2366000.00
IBTA income_statement (quarterly, 2025-09-30) — EBITDA: 3609000.00
IBTA cash_flow (quarterly, 2025-09-30) — End Cash Position: 223354000.00
IBTA cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -37847000.00
IBTA cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 10594000.00
IBTA cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 2209000.00
IBTA income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 22465000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 22364000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 218102000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Gross PPE: 40101000.00
IBTA income_statement (quarterly, 2025-09-30) — Gross Profit: 66118000.00
IBTA cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 243000.00
IBTA income_statement (quarterly, 2025-09-30) — Interest Income: 2510000.00
IBTA income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 2510000.00
IBTA cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 75000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Invested Capital: 329609000.00
IBTA cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -11160000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 4531000.00
IBTA cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
IBTA balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 25342000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 25342000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 4531000.00
IBTA cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -38004000.00
IBTA income_statement (quarterly, 2025-09-30) — Net Income: 1533000.00
IBTA income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 1533000.00
IBTA income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 1533000.00
IBTA income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 1533000.00
IBTA income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 1533000.00
IBTA cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 1533000.00
IBTA income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 1533000.00
IBTA income_statement (quarterly, 2025-09-30) — Net Interest Income: 2510000.00
IBTA income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 2510000.00
IBTA cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -798000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Net PPE: 29619000.00
IBTA cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -7248000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 307245000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 56498000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 56498000.00
IBTA income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 3609000.00
IBTA income_statement (quarterly, 2025-09-30) — Normalized Income: 1533000.00
IBTA cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 21754000.00
IBTA cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 2209000.00
IBTA income_statement (quarterly, 2025-09-30) — Operating Income: 2366000.00
IBTA income_statement (quarterly, 2025-09-30) — Operating Revenue: 83260000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 27098533.00
IBTA balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 19284000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 71100000.00
IBTA income_statement (quarterly, 2025-09-30) — Other Gand A: 22465000.00
IBTA income_statement (quarterly, 2025-09-30) — Other Income Expense: 376000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 22364000.00
IBTA cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 43000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 962000.00
IBTA income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 376000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Other Payable: 98701000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Other Properties: 40101000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Payables: 114012000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 119839000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 10897000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
IBTA income_statement (quarterly, 2025-09-30) — Pretax Income: 5252000.00
IBTA cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 955000.00
IBTA cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -7248000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Receivables: 212822000.00
IBTA income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 16535000.00
IBTA income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1243000.00
IBTA cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -38004000.00
IBTA income_statement (quarterly, 2025-09-30) — Research And Development: 14022000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 58000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -135868000.00
IBTA income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 26629000.00
IBTA income_statement (quarterly, 2025-09-30) — Selling General And Administration: 49094000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Share Issued: 32354468.00
IBTA income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
IBTA cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 10413000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 329609000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 307245000.00
IBTA income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
IBTA income_statement (quarterly, 2025-09-30) — Tax Provision: 3719000.00
IBTA income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
IBTA balance_sheet (quarterly, 2025-09-30) — Total Assets: 569434000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 329609000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Total Debt: 25342000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 329609000.00
IBTA income_statement (quarterly, 2025-09-30) — Total Expenses: 80894000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 239825000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 113974000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 33299000.00
IBTA income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 2366000.00
IBTA income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
IBTA income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
IBTA balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 7957000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 5255935.00
IBTA balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 212028000.00
IBTA balance_sheet (quarterly, 2025-09-30) — Working Capital: 248934000.00
IBTA income_statement (annual, 2025-12-31) — +Operating Expense: 272175000.00
IBTA income_statement (quarterly, 2025-12-31) — +Operating Expense: 71272000.00
IBTA income_statement (annual, 2025-12-31) — +Total Revenue: 342389000.00
IBTA income_statement (quarterly, 2025-12-31) — +Total Revenue: 88526000.00
IBTA balance_sheet (annual, 2025-12-31) — Accounts Payable: 10840000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 10840000.00
IBTA balance_sheet (annual, 2025-12-31) — Accounts Receivable: 208709000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 208709000.00
IBTA balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -3029000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -3029000.00
IBTA balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 692097000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 692097000.00
IBTA balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2494000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2494000.00
IBTA cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 2479000.00
IBTA cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 307000.00
IBTA income_statement (annual, 2025-12-31) — Basic Average Shares: 28366770.00
IBTA income_statement (quarterly, 2025-12-31) — Basic Average Shares: 26265642.00
IBTA income_statement (annual, 2025-12-31) — Basic EPS: 0.13
IBTA income_statement (quarterly, 2025-12-31) — Basic EPS: -0.04
IBTA cash_flow (annual, 2025-12-31) — Beginning Cash Position: 349690000.00
IBTA cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 223354000.00
IBTA cash_flow (annual, 2025-12-31) — Capital Expenditure: -34303000.00
IBTA cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -11175000.00
IBTA cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -14010000.00
IBTA cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -3650000.00
IBTA balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 25501000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 25501000.00
IBTA balance_sheet (annual, 2025-12-31) — Capital Stock: 0.00
IBTA balance_sheet (quarterly, 2025-12-31) — Capital Stock: 0.00
IBTA balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 186612000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 186612000.00
IBTA balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 186612000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 186612000.00
IBTA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -224049000.00
IBTA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -53372000.00
IBTA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -34303000.00
IBTA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -11175000.00
IBTA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 95274000.00
IBTA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 27805000.00
IBTA cash_flow (annual, 2025-12-31) — Change In Account Payable: 355000.00
IBTA cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -1113000.00
IBTA cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -1253000.00
IBTA cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 1781000.00
IBTA cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 3444000.00
IBTA cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 5167000.00
IBTA cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 293000.00
IBTA cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -7128000.00
IBTA cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -2029000.00
IBTA cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -1755000.00
IBTA cash_flow (annual, 2025-12-31) — Change In Payable: 13974000.00
IBTA cash_flow (quarterly, 2025-12-31) — Change In Payable: 7787000.00
IBTA cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 12721000.00
IBTA cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 9568000.00
IBTA cash_flow (annual, 2025-12-31) — Change In Receivables: 10237000.00
IBTA cash_flow (quarterly, 2025-12-31) — Change In Receivables: 4092000.00
IBTA cash_flow (annual, 2025-12-31) — Change In Working Capital: 24666000.00
IBTA cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 9944000.00
IBTA cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 10237000.00
IBTA cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 4092000.00
IBTA cash_flow (annual, 2025-12-31) — Changes In Cash: -163078000.00
IBTA cash_flow (quarterly, 2025-12-31) — Changes In Cash: -36742000.00
IBTA balance_sheet (annual, 2025-12-31) — Common Stock: 0.00
IBTA balance_sheet (quarterly, 2025-12-31) — Common Stock: 0.00
IBTA balance_sheet (annual, 2025-12-31) — Common Stock Equity: 287651000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 287651000.00
IBTA cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
IBTA cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
IBTA cash_flow (annual, 2025-12-31) — Common Stock Payments: -232971000.00
IBTA cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -54791000.00
IBTA income_statement (annual, 2025-12-31) — Cost Of Revenue: 71055000.00
IBTA income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 18896000.00
IBTA balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 7808000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 7808000.00
IBTA balance_sheet (annual, 2025-12-31) — Current Assets: 407925000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Current Assets: 407925000.00
IBTA balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 2935000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 2935000.00
IBTA balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 2935000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 2935000.00
IBTA balance_sheet (annual, 2025-12-31) — Current Liabilities: 207760000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 207760000.00
IBTA cash_flow (annual, 2025-12-31) — Deferred Income Tax: 3146000.00
IBTA cash_flow (annual, 2025-12-31) — Deferred Tax: 3146000.00
IBTA cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 8320000.00
IBTA cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 2467000.00
IBTA income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 3914000.00
IBTA income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 1258000.00
IBTA cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 8320000.00
IBTA cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 2467000.00
IBTA income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 3914000.00
IBTA income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 1258000.00
IBTA income_statement (annual, 2025-12-31) — Diluted Average Shares: 30100579.00
IBTA income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 26265642.00
IBTA income_statement (annual, 2025-12-31) — Diluted EPS: 0.12
IBTA income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.04
IBTA income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 3575000.00
IBTA income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -1003000.00
IBTA income_statement (annual, 2025-12-31) — EBIT: -841000.00
IBTA income_statement (quarterly, 2025-12-31) — EBIT: -1642000.00
IBTA income_statement (annual, 2025-12-31) — EBITDA: 7479000.00
IBTA income_statement (quarterly, 2025-12-31) — EBITDA: 825000.00
IBTA cash_flow (annual, 2025-12-31) — End Cash Position: 186612000.00
IBTA cash_flow (quarterly, 2025-12-31) — End Cash Position: 186612000.00
IBTA cash_flow (annual, 2025-12-31) — Financing Cash Flow: -224049000.00
IBTA cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -53372000.00
IBTA cash_flow (annual, 2025-12-31) — Free Cash Flow: 60971000.00
IBTA cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 16630000.00
IBTA cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 8762000.00
IBTA cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 2208000.00
IBTA income_statement (annual, 2025-12-31) — General And Administrative Expense: 88244000.00
IBTA income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 22129000.00
IBTA balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 24193000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 24193000.00
IBTA balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 211203000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 211203000.00
IBTA balance_sheet (annual, 2025-12-31) — Gross PPE: 36364000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Gross PPE: 36364000.00
IBTA income_statement (annual, 2025-12-31) — Gross Profit: 271334000.00
IBTA income_statement (quarterly, 2025-12-31) — Gross Profit: 69630000.00
IBTA cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 5147000.00
IBTA cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 814000.00
IBTA cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 247000.00
IBTA cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 76000.00
IBTA balance_sheet (annual, 2025-12-31) — Invested Capital: 287651000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Invested Capital: 287651000.00
IBTA cash_flow (annual, 2025-12-31) — Investing Cash Flow: -34303000.00
IBTA cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -11175000.00
IBTA balance_sheet (annual, 2025-12-31) — Investments And Advances: 4531000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 4531000.00
IBTA cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
IBTA cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
IBTA balance_sheet (annual, 2025-12-31) — Leases: 17138000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Leases: 17138000.00
IBTA balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 25501000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 25501000.00
IBTA balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 25501000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 25501000.00
IBTA balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 4531000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 4531000.00
IBTA balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 8774000.00
IBTA balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 8774000.00
IBTA cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -232971000.00
IBTA cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -54791000.00
IBTA income_statement (annual, 2025-12-31) — Net Income: 3575000.00
IBTA income_statement (quarterly, 2025-12-31) — Net Income: -1003000.00
IBTA income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 3575000.00
IBTA income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -1003000.00
IBTA income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 3575000.00
IBTA income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -1003000.00
IBTA income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 3575000.00
IBTA income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1003000.00
IBTA income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 3575000.00
IBTA income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1003000.00
IBTA cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 3575000.00
IBTA cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -1003000.00